Wed, August 16, 2023
Tue, August 15, 2023
Mon, August 14, 2023
Sun, August 13, 2023
Fri, August 11, 2023

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $54 on, Aug 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-54-on-aug-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $54 on, Aug 14th, 2023.

Raghuram has made no other calls on URGN in the last 4 months.



There are 2 other peers that have a rating on URGN. Out of the 2 peers that are also analyzing URGN, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Choi of "Goldman Sachs" Maintained at Hold with Increased Target to $18 on, Monday, July 31st, 2023


This is the rating of the analyst that currently disagrees with Raghuram


  • Leland Gershell of "Oppenheimer" Reiterated at Buy and Held Target at $22 on, Monday, May 15th, 2023

Publication Contributing Sources